The Buyer Clarity Gap Why CMOs & CROSs Lose Deals They Should Win

Life science OEM companies are losing deals not due to inferior products, but because their go-to-market models fail to engage the full buying committee. Procurement decisions now span clinical, financial, technical, and strategic stakeholders, creating a gap between product excellence and buyer confidence—a critical liability.

This white paper explores stalled deals and offers a framework for modern buyer engagement. Key insights include:

• Why clinical champions alone cannot close complex deals
• How multi-tiered value propositions drive stronger outcomes
• The case for post-sale service as a growth asset

Read the full white paper for more.